St. Louis, MO, United States of America

Patrick B Mullins


Average Co-Inventor Count = 16.4

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2002-2006

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Profile of Inventor Patrick B. Mullins

Introduction

Patrick B. Mullins is an accomplished inventor based in St. Louis, MO, known for his contributions to the field of protease inhibitors. With a total of three patents to his name, Mullins has made significant strides in the development of compounds that could have a profound impact on the treatment of various pathological conditions.

Latest Patents

Mullins' recent patents reflect his innovative work in chemistry and pharmacology. One notable invention is focused on piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids. This invention aims at developing selective inhibitors for matrix metalloproteinases (MMPs), which are relevant to numerous diseases. These compounds have been shown to inhibit MMP activity effectively and may be utilized in treating conditions associated with MMP and aggrecanase activity.

Another important patent involves an aromatic sulfone hydroxamic acid metalloprotease inhibitor. This treatment process highlights the potential of an effective enzyme inhibitor that selectively targets specific MMP enzymes while minimizing the inhibition of others. The disclosed compounds show promise for pharmaceutical applications, aiming to provide targeted therapeutic effects with fewer side effects.

Career Highlights

Throughout his career, Patrick B. Mullins has worked for prominent companies, including Pharmacia Corporation and Monsanto Company. His experiences at these organizations have enriched his background and expertise, allowing him to contribute valuably to the field of medicinal chemistry.

Collaborations

Mullins has collaborated with esteemed individuals in his area of expertise, specifically with Thomas E. Barta and Daniel Paul Becker. Their collective knowledge and efforts have undoubtedly contributed to the success and impact of Mullins' inventions.

Conclusion

Patrick B. Mullins stands out as an inventive force in the realm of biochemistry, particularly in developing therapeutic agents targeting protease activity. His work not only enhances our understanding of proteinase inhibitors but also opens new avenues for medical treatments related to aggressive diseases. As his inventions gain recognition, they continue to showcase the importance of innovation in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…